More issues

The Requirements Checklist to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Blue Cross Blue Shield in New Jersey: Forms, Appeals, and PA Guide

Answer Box: Getting Enhertu Covered by Blue Cross Blue Shield in New Jersey Eligibility: HER2-positive unresectable/metastatic breast cancer or other FDA-approved HER2-expressing tumors after prior anti-HER2 therapy. Fastest path: Submit prior authorization via Horizon BCBS Provider Portal or MagellanRx (1-800-424-4508) with HER2 pathology report, treatment history, and monitoring plan.
5 min read

How to Get Natpara (Parathyroid Hormone) Covered by Cigna in North Carolina: Complete 2025 Appeals Guide

Answer Box Getting Natpara (parathyroid hormone) covered by Cigna in North Carolina requires understanding that Takeda discontinued manufacturing in December 2024. New starts are typically denied due to lack of commercial supply. For existing patients, you'll need prior authorization showing chronic hypoparathyroidism, failed conventional therapy (calcium + active vitamin
7 min read

How to Get Tagrisso (Osimertinib) Covered by UnitedHealthcare in Michigan: Appeals Guide & Formulary Alternatives

Quick Answer: Getting Tagrisso Covered by UnitedHealthcare in Michigan UnitedHealthcare typically covers Tagrisso (osimertinib) as a Tier 3 specialty drug requiring prior authorization for EGFR-mutant NSCLC. First step: Have your oncologist submit PA documentation including EGFR mutation test results, staging, and medical necessity letter through the UnitedHealthcare provider portal. If
5 min read